IP Library Granted Patent US 9,546,973
Granted Patent B2
US 9,546,973 · App. 14/119,410 · Granted Jan 17, 2017

Peak offset correction for analyte test strip

Inventor: Joanne McIlrath (Inverness, GB)
Assignee: LifeScan Scotland Limited
G01N27/3271G01N27/3274
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,546,973
App. No.
14/119,410
Granted
Jan 17, 2017
Kind
B2
Abstract

Measurement with a test strip having two working electrodes ( 12, 14 ), using the current transient ( 402, 404 ) for each working electrode measured at a predetermined durational offset (Tpred1, Tpred2) from a peak ( 408, 410 ) of the current transient.

Claims (29)

1. A method of determining analyte concentration in physiological fluid, the method comprising:

providing a reagent disposed between a first electrode and a second electrode;

depositing a physiological fluid on the reagent;

causing a physical transformation of an analyte in the physiological fluid into a different from and generating a current transient from each of the first and second electrodes;

determining a peak in the current transient for each of the first and second electrodes;

measuring a value of the current transient at a predetermined temporal offset from the peak of each current transient from each of the first and second electrodes in which the temporal offset for the first electrode comprises a first time offset from the peak of the current transient of the first electrode and the temporal offset from the peak of the current transient of the second electrode comprises a second time offset different from the first time offset; and

calculating the analyte concentration from the measured current values of the first and second electrodes in the measuring step.

2. The method of claim 1 , in which a predetermined temporal offset for the first electrode comprises about 3.3 seconds and a predetermined temporal offset for the second electrode comprises about 2.5 seconds.

3. The method of claim 1 , in which the measured current value from the first electrode is summed together with the measured current value of the second electrode.

4. The method of claim 1 , in which the analyte comprises glucose and the physiological fluid comprises blood.

5. The method of claim 1 , in which the first time offset is greater than the second time offset by about 25%.

6. A method of determining analyte concentration in physiological fluid, the method comprising:

providing a substrate in which a reagent is disposed between a first electrode and a second electrode;

depositing a physiological fluid onto the reagent;

applying an electrical potential to the first and second electrodes to transform an analyte in the physiological fluid into a different form and to generate a current transient from each of the first and second electrodes;

determining a peak in the current transient for each of the first and second electrodes;

measuring a current value of the current transient at a predetermined temporal offset from the peak of each current transient from each of the first and second electrodes in which the temporal offset for the first electrode comprises a first time offset from the peak of the current transient of the first electrode and the temporal offset from the peak of the current transient of the second electrode comprises a second time offset different from the first time offset; and

calculating the analyte concentration from the measured current values of the first and second electrodes in the measuring step.

7. The method of claim 6 , in which a predetermined temporal offset for the first electrode comprises about 3.3 seconds and a predetermined temporal offset for the second electrode comprises about 2.5 seconds.

8. The method of claim 6 , in which the measured current value from the first electrode is summed together with the measured current value of the second electrode.

9. The method of claim 6 , in which the analyte comprises glucose and the physiological fluid comprises blood.

10. The method of claim 6 , in which the first time offset is greater than the second time offset by about 25%.

11. A glucose measurement system to measure an analyte concentration in physiological fluid of a user, the system comprising:

a test strip including a first electrode, a second electrode and a reagent layer having a mediator in a test area disposed proximate the first and second electrodes, the electrodes being connected to corresponding contact pads; and

an analyte meter having a microprocessor and a test circuit in connection with a test strip port that electrically connects the contact pads of the test strip so that, when the test strip is inserted into the test strip port with physiological fluid deposited in the test area, the meter is configured to apply a voltage potential over a duration and measure a current value of a current transient for each of the first electrode and the second electrode at a predetermined duration after a peak of the current transient in which the predetermined duration for the first electrode comprises a first time offset from the peak of the current transient of the first electrode and the predetermined duration from the peak of the current transient of the second electrode comprises a second time offset different from the first time offset, the current value of the current transient for each of the first and second electrodes being representative of the analyte concentration.

12. The method of claim 11 , in which a predetermined duration for the first electrode comprises about 3.3 seconds and a predetermined duration for the second electrode comprises about 2.5 seconds.

13. The method of claim 11 , in which the measured current value from the first electrode is summed together with the measured current value of the second electrode.

14. The system of claim 11 , in which the analyte comprises glucose and the physiological fluid comprises blood.

15. The system of claim 11 , in which the first time offset is greater than the second time offset by about 25%.

Assignments (16)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2026
From: LIFESCAN GLOBAL CORPORATION; LIFESCAN CHINA, LLC; LIFESCAN IP HOLDINGS, LLC
To: LIFESCAN ENTERPRISES LLC
Reel/Frame 075848/0012 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: ANKURA TRUST COMPANY, LLC
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073929/0495 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073929/0316 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSBWILMINGTON SAVINGS FUND SOCIETY, FSB
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073928/0626 →
ASSIGNMENT OF PATENT SECURITY INTERESTS (1ST LIEN) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SUCCESSOR AGENT
Reel/Frame 072567/0482 →
TRANSFER OF SECURITY AGREEMENT RECORDED AT REEL 063740, FRAME 0080 Recorded Nov 12, 2024
From: BANK OF AMERICA, N.A., AS RESIGNING AGENT
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SUCCESSOR AGENT
Reel/Frame 069340/0243 →
TRANSFER OF SECURITY AGREEMENT RECORDED AT REEL 047179, FRAME 0150 Recorded Nov 11, 2024
From: BANK OF AMERICA, N.A., AS RESIGNING AGENT
To: ANKURA TRUST COMPANY, LLC, AS SUCCESSOR AGENT
Reel/Frame 069314/0022 →
RELEASE OF SECOND LIEN PATENT SECURITY AGREEMENT RECORDED OCT. 3, 2018, REEL/FRAME 047186/0836 Recorded Jun 28, 2023
From: BANK OF AMERICA, N.A.
To: LIFESCAN IP HOLDINGS, LLC; JANSSEN BIOTECH, INC.; JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 064206/0176 →
SECOND LIEN PATENT SECURITY AGREEMENT Recorded May 23, 2023
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 063740/0080 →
FIRST LIEN PATENT SECURITY AGREEMENT Recorded May 22, 2023
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 063712/0430 →
CORRECTIVE ASSIGNMENT TO CORRECT THE DELETING PROPERTY NUMBER 6990849, 7169116, 7351770, 7462265,7468125, 7572356, 8093903, 8486245, 8066866 AND ADD 10431140 PREVIOUSLY RECORDED AT REEL: 050839 FRAME: 0634. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded May 12, 2023
From: LIFESCAN SCOTLAND LTD.
To: CILAG GMBH INTERNATIONAL
Reel/Frame 064656/0141 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: CILAG GMBH INTERNATIONAL
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 050840/0006 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: LIFESCAN SCOTLAND LTD.
To: CILAG GMBH INTERNATIONAL
Reel/Frame 050839/0634 →
SECURITY AGREEMENT Recorded Oct 3, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047186/0836 →
SECURITY AGREEMENT Recorded Oct 2, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047179/0150 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 21, 2013
From: MCILRATH, JOANNE
To: LIFESCAN SCOTLAND LIMITED
Reel/Frame 031654/0125 →
Continuity (2)
Provisional Application 61491008 · May 27, 2011
Related Publication 20140202882A1 · Jul 24, 2014